Dr. Richard Pazdur, director of the Food and Drug Administration’s cancer drug office I gotta be fair to Dr. Dr. Richard Pazdur,…
There was tremendous excitement last year at the American Society of Hematology (ASH) meeting about promising new leukemia drugs. There was tremendous…
When is $100,000 a year more expensive than $500,000 a year? The answer: when developing drugs to treat common diseases (e.g., cancer)…
Last week, we discussed new drug approvals that reflected a paradigm shift for cancer drug development and for treatment of people living…
For many years, a lot of people (including us) have called for a new way to look at, diagnose, and treat cancer….